Babylon Holdings Limited (BBLNF)
| Market Cap | 26.00 |
| Revenue (ttm) | 1.15B |
| Net Income (ttm) | -255.58M |
| Shares Out | 25.61M |
| EPS (ttm) | -12.51 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,103 |
| Average Volume | 4,185 |
| Open | 0.0001 |
| Previous Close | 0.0001 |
| Day's Range | 0.0001 - 0.0001 |
| 52-Week Range | n/a |
| Beta | 809.66 |
| RSI | 51.71 |
| Earnings Date | n/a |
About Theseus Pharmaceuticals
Babylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company provides Babylon Cloud and clinical services. Babylon Holdings Limited was founded in 2013 and is headquartered in Austin, Texas. On August 9, 2023, Babylon Inc., along with its affiliate, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware. [Read more]
Financial Performance
In 2022, Babylon Holdings's revenue was $1.11 billion, an increase of 245.88% compared to the previous year's $320.83 million. Losses were -$221.45 million, 186.1% more than in 2021.
Financial StatementsNews
Babylon In Discussions of New Strategic Alternatives for its Businesses
LONDON--(BUSINESS WIRE)--Babylon Holdings Limited (OTC Pink: BBLNF) (“Babylon”, and together with its subsidiaries, the “Group”) today announced that the transaction proposed by AlbaCore Capital LLP (...